Ketamine Therapy is an innovative treatment that is fast-acting and has given positive results for patients with symptoms of depression. Mercyland Psychiatry is one of the few accredited treatment centers for the administration of Spravato (esketamine), which is approved by the FDA for the treatment of medication-resistant depression. It is primarily prescribed to adults whose condition has not been improved with use of antidepressants. These treatments require prolonged monitoring in a clinical setting.